ZFOX yields 175.44% · PFE yields 6.13%● Live data
📍 ZFOX pulled ahead of the other in Year 1
Combined, ZFOX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZFOX + PFE for your $10,000?
ZeroFox Holdings, Inc. operates as an enterprise cybersecurity software-as-a-service company that addresses the full lifecycle of external cyber threats and risks. The company offers ZeroFox Protect that enables organizations to configure protective capabilities to identify and protect their external assets; ZeroFox Predict, a threat intelligence solution that enable customers to directly search across data lake of global threat indicators, tactics, adversary intelligence, exploits, vulnerabilities, and security tools; ZeroFox Detect that provides customers with real-time asset and vulnerability awareness for their external-facing internet digital footprint; ZeroFox Response that enables organizations to provide the 24x7 level of support necessary to respond to external attacks, incidents, data loss or exfiltration, or potential breaches; and ZeroFox Disrupt to report, block, and take down an attack's core components across the internet. It serves customers in various industry verticals, such as education, energy, entertainment, financial services, government healthcare, media, retail, services, and technology. The company was founded in 2013 and is based in Baltimore, Maryland.
Full ZFOX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.